To address the mechanism by which DNR promotes Cyr61 production in B-ALL cells, we evaluated the phosphorylation of the AKT, p38, ERK1/2, and NF-κB pathways in DNR-treated B-ALL cells. The gene discussed is AKT1; the disease is precursor B-cell acute lymphoblastic leukemia.